**Novo Nordisk’s Ozempic Pricing Strategy: A Game-Changer for Investors?**
**market Context: A Shift in Healthcare Affordability**
The healthcare in…
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
